STAT March 12, 2025
Katie Palmer

In letters, lawmakers question if direct-to-consumer deals could influence prescriptions

On Tuesday, a group of senators sent letters to five telehealth companies that offer care through direct-to-consumer portals from pharmaceutical manufacturers Pfizer and Eli Lilly, interrogating their financial relationships. The questions seek to determine whether contracts between pharma and telehealth companies could violate the federal...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Congress / White House, Digital Health, Govt Agencies, Pharma, Pharma / Biotech, Technology, Telehealth
Teladoc partnering with Eli Lilly on self-pay GLP-1 access
Remote patient monitoring in 2025: The major changes physicians need to know about
Millions in the U.S. Live Where Doctors Don’t Practice and Telehealth Doesn't Reach
Without Congressional Action, Telehealth Waivers to Expire March 31
Another Reprieve? Proposed Budget Bill Includes Telehealth, HaH Extensions

Share This Article